BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bartczak A, Zhang J, Adeyi O, Amir A, Grant D, Gorczynski R, Selzner N, Chruscinski A, Levy GA. Overexpression of fibrinogen-like protein 2 protects against T cell-induced colitis. World J Gastroenterol 2017; 23(15): 2673-2684 [PMID: 28487604 DOI: 10.3748/wjg.v23.i15.2673]
URL: https://www.wjgnet.com/1007-9327/full/v23/i15/2673.htm
Number Citing Articles
1
Yue Lu, Na‐Mi Kim, Yi‐Wen Jiang, Hong Zhang, Dan Zheng, Fu‐Xiang Zhu, Rui Liang, Bin Li, Hong‐Xi Xu. Cambogin suppresses dextran sulphate sodium‐induced colitis by enhancing Treg cell stability and functionBritish Journal of Pharmacology 2018; 175(7): 1085 doi: 10.1111/bph.14150
2
Ying Zhu, Jie Zhou, Yi Feng, Liying Chen, Longhui Zhang, Fei Yang, Haoran Zha, Xinxin Wang, Xiao Han, Chi Shu, Yisong Y. Wan, Qi-Jing Li, Bo Guo, Bo Zhu. Control of Intestinal Inflammation, Colitis-Associated Tumorigenesis, and Macrophage Polarization by Fibrinogen-Like Protein 2Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00087
3
Erin Janssen, Mohammad F. Alosaimi, Anas M. Alazami, Abdullah Alsuliman, Ayodele Alaiya, Bandar Al-Saud, Hamoud Al-Mousa, Tariq Jassim Al-Zaid, Emma Smith, Craig D. Platt, Hibah Alruwaili, Sarah Albanyan, Sulaiman M. Al-Mayouf, Raif S. Geha. A homozygous truncating mutation of FGL2 is associated with immune dysregulationJournal of Allergy and Clinical Immunology 2023; 151(2): 572 doi: 10.1016/j.jaci.2022.10.006
4
Olga Luft, Ramzi Khattar, Kaveh Farrokhi, Dario Ferri, Nataliya Yavorska, Jianhua Zhang, Hassan Sadozai, Oyedele Adeyi, Andrzej Chruscinski, Gary A. Levy, Nazia Selzner. Inhibition of the Fibrinogen‐Like Protein 2:FcγRIIB/RIII immunosuppressive pathway enhances antiviral T‐cell and B‐cell responses leading to clearance of lymphocytic choriomeningitis virus clone 13Immunology 2018; 154(3): 476 doi: 10.1111/imm.12897
5
Mahmoud A. Elrebehy, Sarah Al-Saeed, Sara Gamal, Asmaa El-Sayed, Alshaimaa A. Ahmed, Omnia Waheed, Ahmed Ismail, Hesham A. El-Mahdy, Al-Aliaa M. Sallam, Ahmed S. Doghish. miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: A spotlight on signaling pathways interplay — A reviewInternational Journal of Biological Macromolecules 2022; 214: 583 doi: 10.1016/j.ijbiomac.2022.06.134
6
Li Fu, Zheng Liu, Yang Liu. Fibrinogen-like protein 2 in inflammatory diseases: A future therapeutic targetInternational Immunopharmacology 2023; 116: 109799 doi: 10.1016/j.intimp.2023.109799
7
Kristianne J. C. Galpin, Galaxia M. Rodriguez, Vincent Maranda, David P. Cook, Elizabeth Macdonald, Humaira Murshed, Shan Zhao, Curtis W. McCloskey, Andrzej Chruscinski, Gary A. Levy, Michele Ardolino, Barbara C. Vanderhyden. FGL2 promotes tumour growth and attenuates infiltration of activated immune cells in melanoma and ovarian cancer modelsScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-51217-1
8
Muyang Yang, Zhongwei Zhang, Jiajia Chen, Mengying Xu, Jiaquan Huang, Ming Wang, Weina Li, Xiaoyang Wan, Man-Fung Yuen, Xiaoping Luo, Dong Xi, Qin Ning. Soluble fibrinogen-like protein 2 promotes the growth of hepatocellular carcinoma via attenuating dendritic cell-mediated cytotoxic T cell activityJournal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1326-5
9
Murakonda Sahithi, Madhuresh Dwivedi. Challenges and Potential Solutions in Gluten Free Product DevelopmentFood Engineering Series 2022; : 97 doi: 10.1007/978-3-030-88697-4_6
10
Begum Dariya, Ganji Purnachandra Nagaraju. Colon Cancer Diagnosis and Therapy2021; : 1 doi: 10.1007/978-3-030-64668-4_1